BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 26483866)

  • 1. Programmed death-1/programmed death-L1 signaling pathway and its blockade in hepatitis C virus immunotherapy.
    Salem ML; El-Badawy A
    World J Hepatol; 2015 Oct; 7(23):2449-58. PubMed ID: 26483866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. According to Hepatitis C Virus (HCV) Infection Stage, Interleukin-7 Plus 4-1BB Triggering Alone or Combined with PD-1 Blockade Increases TRAF1
    Moreno-Cubero E; Subirá D; Sanz-de-Villalobos E; Parra-Cid T; Madejón A; Miquel J; Olveira A; González-Praetorius A; García-Samaniego J; Larrubia JR
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29093082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined blockade of programmed death-1 and activation of CD137 increase responses of human liver T cells against HBV, but not HCV.
    Fisicaro P; Valdatta C; Massari M; Loggi E; Ravanetti L; Urbani S; Giuberti T; Cavalli A; Vandelli C; Andreone P; Missale G; Ferrari C
    Gastroenterology; 2012 Dec; 143(6):1576-1585.e4. PubMed ID: 22929808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of PD-1 expression on circulating and intrahepatic hepatitis C virus-specific CD8+ T cells associated with reversible immune dysfunction.
    Golden-Mason L; Palmer B; Klarquist J; Mengshol JA; Castelblanco N; Rosen HR
    J Virol; 2007 Sep; 81(17):9249-58. PubMed ID: 17567698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costimulatory molecule programmed death-1 in the cytotoxic response during chronic hepatitis C.
    Larrubia JR; Benito-Martínez S; Miquel J; Calvino M; Sanz-de-Villalobos E; Parra-Cid T
    World J Gastroenterol; 2009 Nov; 15(41):5129-40. PubMed ID: 19891011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The PD-1/PD-L1 (B7-H1) pathway in chronic infection-induced cytotoxic T lymphocyte exhaustion.
    Hofmeyer KA; Jeon H; Zang X
    J Biomed Biotechnol; 2011; 2011():451694. PubMed ID: 21960736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PD-1/PD-L1 signal pathway participates in HCV F protein-induced T cell dysfunction in chronic HCV infection.
    Xiao W; Jiang LF; Deng XZ; Zhu DY; Pei JP; Xu ML; Li BJ; Wang CJ; Zhang JH; Zhang Q; Zhou ZX; Ding WL; Xu XD; Yue M
    Immunol Res; 2016 Apr; 64(2):412-23. PubMed ID: 26286967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1).
    Fuller MJ; Callendret B; Zhu B; Freeman GJ; Hasselschwert DL; Satterfield W; Sharpe AH; Dustin LB; Rice CM; Grakoui A; Ahmed R; Walker CM
    Proc Natl Acad Sci U S A; 2013 Sep; 110(37):15001-6. PubMed ID: 23980172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysfunction and functional restoration of HCV-specific CD8 responses in chronic hepatitis C virus infection.
    Penna A; Pilli M; Zerbini A; Orlandini A; Mezzadri S; Sacchelli L; Missale G; Ferrari C
    Hepatology; 2007 Mar; 45(3):588-601. PubMed ID: 17326153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bim-mediated apoptosis and PD-1/PD-L1 pathway impair reactivity of PD1(+)/CD127(-) HCV-specific CD8(+) cells targeting the virus in chronic hepatitis C virus infection.
    Larrubia JR; Benito-Martínez S; Miquel J; Calvino M; Sanz-de-Villalobos E; González-Praetorius A; Albertos S; García-Garzón S; Lokhande M; Parra-Cid T
    Cell Immunol; 2011; 269(2):104-14. PubMed ID: 21481848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of full CD8 functional restoration after antiviral treatment for acute and chronic hepatitis C virus infection.
    Missale G; Pilli M; Zerbini A; Penna A; Ravanetti L; Barili V; Orlandini A; Molinari A; Fasano M; Santantonio T; Ferrari C
    Gut; 2012 Jul; 61(7):1076-84. PubMed ID: 22337949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrasting Roles of the PD-1 Signaling Pathway in Dendritic Cell-Mediated Induction and Regulation of HIV-1-Specific Effector T Cell Functions.
    Garcia-Bates TM; Palma ML; Shen C; Gambotto A; Macatangay BJC; Ferris RL; Rinaldo CR; Mailliard RB
    J Virol; 2019 Mar; 93(5):. PubMed ID: 30541848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PD-L1 Expression on Retrovirus-Infected Cells Mediates Immune Escape from CD8+ T Cell Killing.
    Akhmetzyanova I; Drabczyk M; Neff CP; Gibbert K; Dietze KK; Werner T; Liu J; Chen L; Lang KS; Palmer BE; Dittmer U; Zelinskyy G
    PLoS Pathog; 2015 Oct; 11(10):e1005224. PubMed ID: 26484769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional Expression of Programmed Death-Ligand 1 (B7-H1) by Immune Cells and Tumor Cells.
    Gibbons Johnson RM; Dong H
    Front Immunol; 2017; 8():961. PubMed ID: 28848559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B.
    Fisicaro P; Valdatta C; Massari M; Loggi E; Biasini E; Sacchelli L; Cavallo MC; Silini EM; Andreone P; Missale G; Ferrari C
    Gastroenterology; 2010 Feb; 138(2):682-93, 693.e1-4. PubMed ID: 19800335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells.
    Xiang J; Zhang N; Sun H; Su L; Zhang C; Xu H; Feng J; Wang M; Chen J; Liu L; Shan J; Shen J; Yang Z; Wang G; Zhou H; Prieto J; Ávila MA; Liu C; Qian C
    Gastroenterology; 2020 Feb; 158(3):664-678.e24. PubMed ID: 31678303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of antiviral treatment on expression of programmed death 1 and programmed death ligand 1 on peripheral T lymphocytes in patients with chronic hepatitis C].
    Cai RT; Shen L; Zhao W; Yang YF; Zhang YC
    Zhonghua Gan Zang Bing Za Zhi; 2013 Apr; 21(4):261-6. PubMed ID: 24021786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4 T Cell Depletion Substantially Augments the Rescue Potential of PD-L1 Blockade for Deeply Exhausted CD8 T Cells.
    Penaloza-MacMaster P; Provine NM; Blass E; Barouch DH
    J Immunol; 2015 Aug; 195(3):1054-63. PubMed ID: 26116499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HBeAg seroconversion is associated with a more effective PD-L1 blockade during chronic hepatitis B infection.
    Ferrando-Martinez S; Huang K; Bennett AS; Sterba P; Yu L; Suzich JA; Janssen HLA; Robbins SH
    JHEP Rep; 2019 Sep; 1(3):170-178. PubMed ID: 32039367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression.
    Radziewicz H; Ibegbu CC; Fernandez ML; Workowski KA; Obideen K; Wehbi M; Hanson HL; Steinberg JP; Masopust D; Wherry EJ; Altman JD; Rouse BT; Freeman GJ; Ahmed R; Grakoui A
    J Virol; 2007 Mar; 81(6):2545-53. PubMed ID: 17182670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.